ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $2,000 | +100.0% | 300 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | – | 300 | 0.0% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 300 | 0.0% | 0.00% | – |
Q3 2018 | $1,000 | -90.9% | 300 | -89.6% | 0.00% | – |
Q2 2018 | $11,000 | 0.0% | 2,879 | 0.0% | 0.00% | – |
Q1 2018 | $11,000 | +22.2% | 2,879 | -12.2% | 0.00% | – |
Q4 2017 | $9,000 | 0.0% | 3,279 | +57.7% | 0.00% | – |
Q3 2017 | $9,000 | -25.0% | 2,079 | -19.4% | 0.00% | – |
Q2 2017 | $12,000 | -70.0% | 2,579 | -72.8% | 0.00% | -100.0% |
Q1 2017 | $40,000 | – | 9,479 | +11898.7% | 0.00% | – |
Q4 2016 | $0 | -100.0% | 79 | -55.9% | 0.00% | – |
Q3 2016 | $2,000 | 0.0% | 179 | 0.0% | 0.00% | – |
Q2 2016 | $2,000 | -92.0% | 179 | -94.3% | 0.00% | – |
Q1 2016 | $25,000 | -56.1% | 3,154 | -40.0% | 0.00% | -100.0% |
Q4 2015 | $57,000 | -42.4% | 5,254 | -63.3% | 0.00% | -50.0% |
Q3 2015 | $99,000 | -22.0% | 14,312 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $127,000 | -9.9% | 14,312 | 0.0% | 0.00% | -33.3% |
Q1 2015 | $141,000 | -19.4% | 14,312 | 0.0% | 0.00% | -25.0% |
Q4 2014 | $175,000 | +19.0% | 14,312 | -3.1% | 0.00% | 0.0% |
Q3 2014 | $147,000 | +25.6% | 14,772 | -4.8% | 0.00% | +33.3% |
Q2 2014 | $117,000 | +28.6% | 15,512 | -44.0% | 0.00% | 0.0% |
Q1 2014 | $91,000 | +82.0% | 27,700 | +84.7% | 0.00% | +50.0% |
Q4 2013 | $50,000 | +525.0% | 15,000 | +500.0% | 0.00% | – |
Q3 2013 | $8,000 | -60.0% | 2,500 | 0.0% | 0.00% | -100.0% |
Q2 2013 | $20,000 | – | 2,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
IFP Advisors, Inc | 0 | $0 | 0.00% |